Harri Makivuokko,Jaana Matto,Pirjo Wacklin,Jukka Partanen,Jarkko Rabina
申请号：
US13703564
公开号：
US20130101560A1
申请日:
2011.06.13
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present invention relates to use of the ABO blood group genotype of an individual as a criterion for microbiota modulation that is tailored based on the differences in the spectrum of bacteria found between individuals with different ABO blood group genotypes. The present invention relates further to a microbial composition tailored based on the microbial genotypes shown to be specific for A, B, and/or O blood groups.
